Ignite Creation Date:
2024-05-06 @ 2:05 AM
Last Modification Date:
2024-10-26 @ 11:13 AM
Study NCT ID:
NCT01967875
Status:
TERMINATED
Last Update Posted:
2019-05-30
First Post:
2013-10-15
Brief Title:
A Phase 2 Trial of Optimizing Platinum-Based Chemotherapy Based on ERCC1 Expression as First-Line Treatment in Patients With Locally Advanced or Metastatic Gastric Cancer
Sponsor:
China Medical University China
Organization:
China Medical University China
Organization Data
Organization:
China Medical University China
Class:
OTHER
Study ID:
CLOG1301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
China Medical University China
Lead Sponsor Class:
OTHER
Responsible Party:
Yunpeng Liu
Responsible Party Title:
MDPhD
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
China Medical University China
Old Name:
None
Old Organization:
None